Share：
Share this content in WeChat
X
[Chinese][PDF]7278
• Editorial •
Application and development of MR imaging on Breast diseases
ZHOU Chun-wu  ZHAO Li-yun  LI Jing 

DOI:10.3969/j.issn.1674-8034.2014.05.S1.012.


[Abstract] Breast cancer is the most common malignant tumor in women. Breast imaging plays an important role in breast cancer diagnosis, choice of treatment, assessment of efficacy and the follow-up monitoring post treatment. In this paper, On the basis of a large number of domestic and foreign Literature , The author elaborates the status of the breast imaging methods commonly used (mammography, breast ultrasound, breast MRI, PET-CT and other breast imaging technology) and its clinical application comprehensively and briefly.
[Keywords] Breast diseases；Progress；Magnetic resonance imaging

ZHOU Chun-wu * Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

ZHAO Li-yun Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

LI Jing Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

*Correspondence to: Zhou CW, E-mail: cjr.zhouchunwu@vip.163.com

Conflicts of interest   None.

Received  2014-08-17
Accepted  2014-09-25
DOI: 10.3969/j.issn.1674-8034.2014.05.S1.012
DOI:10.3969/j.issn.1674-8034.2014.05.S1.012.

[1]
Wasif N, Garreau J, Terando A, et al. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg, 2009, 75(10):970-975.
[2]
李静，周纯武，欧阳汉，等．MRI对乳腺癌术前评估的价值：与X线摄影、超声比较．中国医学影像技术, 2009, 25(12):2150-2153.
[3]
Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol, 2004, 183(4):1149-1157.
[4]
Lord S J, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. European Journal of Cancer, 2007, 43(13):1905-1917.
[4]
Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicenter cohort study (MARIBS). Lancet, 2005, 365(9473):1769-1778.
[6]
Griebsch I, Brown J, Boggis C, Dixon A, et al. Costeffectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer, 2006, 95(7):801-810.
[7]
Smith RA1, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin, 2014, 64(1):30-51.
[8]
Chou CP, Wu M T, Chang HT, et al. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Acad Radiol, 2007, 14 (5):561-573.
[9]
Park S H, Moon W K, Cho N, et al. Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol, 2012, 22 (1):18-25.
[10]
Kong X, Moran M S, Zhang N, et al. Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients. Eur J Cancer, 2011, 47 (14):2084-2090.
[11]
Ah-See ML, Makris A, Taylor N J, et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res, 2008, 14 (20):6580-6589.
[12]
Fangberget A, Nilsen L B, Hole K H, et al. Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol, 2011, 21(6):1188-1199.
[13]
Mcguire KP, Toro-Burguete J, Dang H, et al. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?. Ann Surg Oncol, 2011, 18(11): 3149-3154.
[14]
Li X, Welch EB, Arlinghaus LR, et al. A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer. Phys Med Biol, 2011, 56(17):5753-5769.
[15]
Blair S, McElroy M, Middleton MS, et al. The efficacy of breast MRI in predicting breast conservation therapy. J Surg Oncol, 2006, 94(3):220-225.
[16]
Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol, 2000, 175(6): 1577-1584.
[17]
American College of Radiology. ACR practice guideline for the performance of contrast enhanced magnetic resonance imaging (MRI) of the breast. Reston, Va: American College of Radiology, 2008.
[18]
Drukteinis JS, Gombos EC, Raza S, et al. MR imaging assessment of the breast after breast conservation therapy: distinguishing benign from malignant lesions. Radiographics, 2012, 32(1):219-234.
[19]
Mann RM, Kuhl CK, Kinkel K, et al. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol, 2008, 18(7):1307-1318.
[20]
Moms EA. Diagnostic breast MR imaging-current status and future directions. Magn Reson Imaging Clin N Am, 2010, 18(1):57-74.
[21]
顾雅佳，徐玲辉，张盛箭，等. MR导引的乳腺病变定位方法及其病变特征分析．中华放射学杂志, 2013, 47(8):685-689.
[22]
程流泉，王建东，刘梅，等. MRI引导乳腺活组织穿刺检查的初步研究．中国医学影像学杂志, 2011, 19(2):129-133.
[23]
李瑞敏，顾雅佳，毛健，等．定量动态增强MRI鉴别乳腺良恶性病变的研究．中华放射学杂志, 2011, 45(2):164-169.
[24]
张青，王振常，鲜军舫，等．乳腺癌增强MRI特征与病理、免疫组化指标的相关性研究．磁共振成像, 2012, 3(6): 430-433.
[25]
李敏，金真，李功杰，等．乳腺动态增强MRI参数与肿瘤血管的相关性及其鉴别诊断价值.磁共振成像, 2010,1(1):36-42.
[26]
韦苇，谢东，苏丹柯，等．乳腺癌MRI非形态学特征与C-erbB-2表达的相关性研究.磁共振成像, 2014, 5(4): 269-273.
[27]
Koo HR, Cho N, Song IC, et al. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers. J Magn Reson Imaging, 2012, 36(1): 145-151.
[28]
Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology, 1986, 161(2): 401-407.
[29]
Liu, C., et al. (2013). Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI. Eur J Radiol, 82(12): 782-789.
[30]
Sigmund EE, Cho GY, Kim S, et al. Intravoxel Incoherent Motion Imaging of Tumor Microenvironment in Locally Advanced Breast Cancer. Magnetic Resonance in Medicine, 2011, 65(5): 1437-1447.
[31]
周纯武，张仁知．乳腺影像学的现状与使命．磁共振成像, 2014, 5(4): 241-245.

PREV Application and advance of MR imaging on musculoskeletal diseases
NEXT Application and development of magnetic resonance imaging in glioma
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn